Picard on Health: Mixed medicine and messages
AIMS President and CEO Charles Cirtwill reflects on Picard's recent healthcare talk in Halifax.
By Atlantic Institute for Market Studies| 2012-03-28T00:00:00+00:00 March 28th, 2012|In the Media|
AIMS President and CEO Charles Cirtwill reflects on Picard's recent healthcare talk in Halifax.
By Atlantic Institute for Market Studies| 2012-03-20T00:00:00+00:00 March 20th, 2012|In the Media|
AIMS Health Policy Fellow David Zitner argues that the two-tiered system of government funded healthcare that currently exists in Canada is likely not what Tommy Douglas had in mind.
By Atlantic Institute for Market Studies| 2012-02-14T00:00:00+00:00 February 14th, 2012|In the Media|
AIMS Health Policy Fellow David Zitner points out that neither the health districts nor the provincial government are able to measure the costs or benefits of care when the Department of Health spends your health dollars.
By Atlantic Institute for Market Studies| 2012-01-26T00:00:00+00:00 January 26th, 2012|Newsletters|
AIMS contributors discuss Healthy Alternatives for our health care system, will Generation Y ever get that special feeling for Atlantic Canada?, Canada's system of regional subsidies has to change, why minimum wage increases are a costly way to make little progress, the importance of immigration, and why big economic players need remedying policies.
By David Zitner and George Cooper| 2016-03-30T13:11:37+00:00 January 18th, 2012|Op-ed|
AIMS is pleased to provide a forum for fresh perspectives on the Canadian public health care system. AIMS Health Policy Fellow David Zitner and AIMS Board Director George Cooper offer their points of view on what can be done to fix a system in need.
By Atlantic Institute for Market Studies| 2012-01-16T00:00:00+00:00 January 16th, 2012|In the Media|
AIMS Board Member George Cooper explains that no progress can be made in our health care system until we fix its governance.
By Atlantic Institute for Market Studies| 2012-01-16T00:00:00+00:00 January 16th, 2012|Newsletters|
The Effectiveness of the Common Drug Review in Canada's National Drug Strategy, PRPPs are compared to other options, Bill Black discusses Halifax's potential stadium and the provincial government's request for RHAs to cut spending, AIMS President & CEO Charles Cirtwill on investing in children, AIMS submission to the HoC re: CETA negotiations is outlined.
By Atlantic Institute for Market Studies| 2012-01-11T00:00:00+00:00 January 11th, 2012|In the Media|
Tommy Douglas dreamed of a world where rich and poor alike had access to worthwhile and high-quality care. AIMS Health Policy Fellow David Zitner writes that instead, Canadian rich and poor pay the same amount for care — nothing — but the care they receive is different.
By Atlantic Institute for Market Studies| 2012-01-10T00:00:00+00:00 January 10th, 2012|In the Media|
As NS Premier Dexter opposes the federal plan to pay health transfers to the provinces on a per capita basis, AIMS points out there is already unequal health care, but this plan will create more divergence.
By Amir Attaran, Rosario Cartagena, and Andree Taylor| 2016-04-05T14:41:11+00:00 December 20th, 2011|Policy Papers|
This paper examines the degree to which provincial drug plans reflect the results of the Common Drug Review, ultimately finding that the review has NOT resulted in consistent availability to pharmaceuticals across the provinces.